 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present virtually at the Baird 2021 Global Healthcare Conference on September 14 at 4:20 p.m. Eastern Time. The fireside chat will be webcast live and can 